Sunday, September 13, 2020

AstraZeneca resumes clinical trials in UK after green signal

Meanwhile, DCGI asks Serum Institute to submit DSMB UK and India data to resume trials, after asking it to stop recruiting volunteers on Friday

from Today's Paper https://ift.tt/2ZxYA5w
via

No comments:

Post a Comment

If you have any doubts please let me know!

India's low score on GVC a starting point for recovery from pandemic: AIIB

India rated 7.4 percentage points below the average global value chain participation rate for emerging economies from Today's Paper ht...